SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stephen C. Harris, Peter J. Perrino, Ira Smith, Megan J. Shram, Salvatore V. Colucci, Cynthia Bartlett, Edward M. Sellers, Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users, The Journal of Clinical Pharmacology, 2014, 54, 4
  2. 2
    Joshua B. Radke, Kelly P. Owen, Mark E. Sutter, Jonathan B. Ford, Timothy E. Albertson, The Effects of Opioids on the Lung, Clinical Reviews in Allergy & Immunology, 2014, 46, 1, 54

    CrossRef

  3. 3
    W. B. Fang, M. R. Lofwall, S. L. Walsh, D. E. Moody, Determination of Oxycodone, Noroxycodone and Oxymorphone by High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry in Human Matrices: In vivo and In vitro Applications, Journal of Analytical Toxicology, 2013, 37, 6, 337

    CrossRef

  4. 4
    Michelle R. Lofwall, Shanna Babalonis, Paul A. Nuzzo, Anthony Siegel, Charles Campbell, Sharon L. Walsh, Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial, Drug and Alcohol Dependence, 2013, 133, 1, 188

    CrossRef

  5. 5
    Peter J. Perrino, Salvatore V. Colucci, Glen Apseloff, Stephen C. Harris, Pharmacokinetics, Tolerability, and Safety of Intranasal Administration of Reformulated OxyContin® Tablets Compared with Original OxyContin® Tablets in Healthy Adults, Clinical Drug Investigation, 2013, 33, 6, 441

    CrossRef

  6. 6
    Stanislas Grassin-Delyle, Amparo Buenestado, Emmanuel Naline, Christophe Faisy, Sabine Blouquit-Laye, Louis-Jean Couderc, Morgan Le Guen, Marc Fischler, Philippe Devillier, Intranasal drug delivery: An efficient and non-invasive route for systemic administration, Pharmacology & Therapeutics, 2012, 134, 3, 366

    CrossRef